Cerevia Neurosciences

Active, new domainAI-native

Cerevia Neurosciences is a full stack closed-loop image-guide network neuromodulation platform that integrates fMRI and AI-driven personalization to treat dementia.

What it does

Cerevia Neuroscience is a lifetech company developing a full-stack closed-loop neuromodulation platform designed to treat dementia. The platform integrates deep transcranial magnetic stimulation (TMS) with functional MRI and AI-driven personalization, enabling tailored therapeutic interventions. By combining advanced neurostimulation techniques with real-time brain imaging and artificial intelligence, Cerevia Neuroscience aims to enhance treatment efficacy and patient outcomes. This innovative approach represents a significant advancement in neuromodulation technology, offering a novel solution for addressing complex neurological disorders such as dementia.

How it has moved

  • new domain

    The site moved to cerevia.care, same company.

Next to it in Healthcare and bio · AI-personalized closed-loop neuromodulation for dementia

  • CortisysSOSV SOSV HAX Seed 2025

    Unlocking the potential

  • Surf TherapeuticsSOSV SOSV HAX Seed 2025

    Non-Invasive, At-home Ultrasound Neuromodulation for Chronic Inflammatory Disorders.

  • OmantaY Combinator S26

    A research lab for one

  • TareBioY Combinator S26

    Vaccines for any cancer or infection in weeks.

  • Edulis TherapeuticsPlug and Play PnP 2026

    Founded by an Ex-NASA engineer and two gastroenterologists, Edulis is building the first drug delivery system for sustained, localized treatment of chronic GI diseases like IBD and colorectal cancer.

  • ENF MedicalPlug and Play PnP 2026

    ENF Medical develops ENgraft, a scalable, bioresorbable bone graft platform—from dental to long-bone defects—designed for surgeons to regenerate bone, improve healing, and reduce repeat surgeries.

  • Humimic BiosystemsPlug and Play PnP 2026

    Humimic Biosystems provides organ-on-chip models for human-relevant preclinical research and drug testing.

  • LevisonicsPlug and Play PnP 2026

    Levisonics is developing a drop-of-blood, point-of-care coagulation analyzer that delivers in a single test the comprehensive clotting insights that today require multiple separate lab and point-of-care tests.